Story perspectives

FDA appoints Mike Davis, ousts Hoeg amid controversy

5/16/2026

Summary

Story summary

Acting director Tracy Beth Hoeg was removed from the FDA drug center.
Dr. Mike Davis was named the new director of the drug center.
The shift followed FDA Commissioner Marty Makary’s resignation and vaccine chief Vinay Prasad’s departure.
Hoeg, a physician with no government management experience, oversaw RSV, antidepressant and COVID-19 vaccine investigations and supported President Donald Trump’s effort to drop certain childhood vaccines, which a Boston federal judge blocked.

1 of 1

Story summary

Acting director Tracy Beth Hoeg was removed from the FDA drug center.
Dr. Mike Davis was named the new director of the drug center.
The shift followed FDA Commissioner Marty Makary’s resignation and vaccine chief Vinay Prasad’s departure.
Hoeg, a physician with no government management experience, oversaw RSV, antidepressant and COVID-19 vaccine investigations and supported President Donald Trump’s effort to drop certain childhood vaccines, which a Boston federal judge blocked.